{
  "docId": "019de517-ef27-7380-abf1-7804147a21c1",
  "docSlug": "35bb8af5e32b82874d7685e3939f2cc9",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 39 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 24,
  "pageCount": 39,
  "prevPage": 23,
  "nextPage": 25,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de517-ef27-7380-abf1-7804147a21c1/24",
  "deckHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1",
  "deckJsonHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1.json",
  "deckAnchorHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1#slide-24",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.603,
        "x": 0.045,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1. See Slide 1 for further information on forward-looking statements.\n2. In 2019, the Company acquired an exclusive license from Novaliq GmbH for the commercialization and development of Miebo in the United States and Canada.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a128fc08-1c58-4745-b746-7bd4164204d7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.75,
        "w": 0.91,
        "x": 0.045,
        "y": 0.16
      },
      "kind": "table",
      "text": "Product: Miebo, SiHy Daily, Lumify Expansion Opportunities, SeeLuma Fully Digital Surgical Visualization Platform (3D Microscope), eyeTELLIGENCE Digital Platform, IC-8 Apthera, MIMS Minimally Invasive Surgical Procedure, enVista Envy Trifocal IOL, enVista Aspire Extended Range Monofocal IOL, enVista Beyond Extended Depth of Focus IOL. Status: Available in U.S., Filed in Canada 1Q23; Launched SVS in ~50 countries, including China in 2Q23; Multifocal launched in U.S. and Japan; Eye Illuminations – Launching now in U.S., Preservative Free submitted 2Q23; Available in U.S. and Western Europe; Beta software testing ongoing. Regulatory assessments complete; Available in select markets across Europe, as well as in Australia, New Zealand and Singapore; Entered into exclusive European distribution agreement with Sanoculis; Canada, EU and U.S. submissions in process; Available in U.S.; Canada submitted 1Q23, EU submitted 2Q23; Clinical study expected to begin 2Q24. Catalysts to Watch: U.S. launch in process, Canada approval expected 2024; Geo-expansion continues, Toric launch expected in 2024; Preservative Free approval expected in 2024, Allergy submission expected 2024; Additional countries expected to follow; U.S. commercial release in process; U.S. launch in process; EU launch in process; Expect U.S. and Canada launch in 2024, EU 2025 (includes Toric versions and new EyeGility inserter); U.S. launch in process (includes Toric; new EyeGility inserter to be added in 2024), EU launch expected in 2024 with EyeGility inserter; Expect 2026 launch.",
      "attrs": {
        "columns": [
          {
            "width": 0.28,
            "header": "Product"
          },
          {
            "width": 0.36,
            "header": "Status"
          },
          {
            "width": 0.36,
            "header": "Catalysts to Watch"
          }
        ],
        "header_rows": 1
      },
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d67ebd2-2755-48aa-a9ec-613fd9feb4c6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.769,
        "x": 0.045,
        "y": 0.08
      },
      "kind": "title",
      "text": "Early Stage Launches and Near-term Pipeline Products to Watch",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e454b9c-d7ef-4227-ac58-d5f5cb207b49",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 39,
      "from": 22,
      "beatId": "8c7af079-c074-453d-8134-b8959b29a800",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The appendix and Q&A section provide satisfaction and answers to questions",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}